ArticleJournal for immunotherapy of cancer2025

Machine learning identifies clinical tumor mutation landscape pathways of resistance to checkpoint inhibitor therapy in NSCLC.

Vitalay Fomin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.